Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
AyurMaya: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
AyurMaya
AyurMaya
Active
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Apr 1, 2024
Endeavor BioMedicines
$130.0M Series C
AyurMaya
, Karan Takhar
Atlas Venture
,
Hatteras Venture Partners
,
Omega Funds
,
RA Capital
,
Roche Venture Fund
,
abrdn
, Ally Bridge Group
,
Avidity Partners
,
Eckuity Capital
, Fidelity Management & Research Company
,
Invus
,
Longitude Capital
,
Perceptive Advisors
, Piper Heartland Healthcare Capital
,
Silver Arch Bio
, SymBiosis
, T. Rowe Price Associates
,
Velosity Capital
,
Woodline Partners
Mar 1, 2024
Alumis
$260.0M Series C
Foresite Capital
, Srinivas Akkaraju
ARCH Venture Partners
,
Atlas Venture
,
Deerfield Management
,
F-Prime Capital Partners
,
The Column Group
,
venBio
, Ally Bridge Group
,
Cormorant Asset Management
, HBM Healthcare Investments
,
Lilly Asia Ventures
,
Nextech
,
Omega Funds
, Piper Heartland Healthcare Capital
,
SR One
Sep 1, 2023
ReCode Therapeutics
$50.0M Series B
—
Bioluminescence Ventures
, InterWest
,
Intuitive Ventures
,
MPM Capital
,
OrbiMed
,
Pfizer Venture Investments
,
Polaris Partners
,
Vida Ventures
, Sam Altman
,
Amgen Ventures
,
EcoR1 Capital
,
Leaps by Bayer
,
Osage University Partners
,
Sanofi Ventures
,
Solasta Ventures
May 1, 2023
ElevateBio
$400.0M Series D
AyurMaya
,
Matrix Capital Management
MPM Capital
,
RA Capital
,
EcoR1 Capital
,
EDBI
, Emerson Collective
,
F2 Ventures
, Fidelity Management & Research Company
, Khalil Barrage
,
Lee Family Office
, Karina Thorn
,
R&D partner
,
Redmile Group
,
Samsara BioCapital
, SoftBank
, Surveyor Capital
,
Vertex Ventures
,
Woodline Partners
Sep 1, 2022
ACELYRIN
$300.0M Series C
Access Biotechnology
Atlas Venture
, Contrary Capital
,
Mott Family Capital
, Matthew McAviney
, Robert Garland
,
venBio
,
Westlake Village BioPartners
, Ron Pragides
, Cowen Healthcare Investments
,
Decheng Capital
,
Marshall Wace
,
OrbiMed
,
Samsara BioCapital
, Surveyor Capital
,
Tybourne Capital Management
Jun 29, 2022
ReCode Therapeutics
$120.0M Series B Extension
Alan Colowick
, Juergen Eckhardt
Amgen Ventures